Cancer cachexia impacts almost 90% of people living with pancreatic cancer. Learn more about this condition in this Q&A with Nicolas Clifford, PanCAN’s manager of research and education communication.

Background Cardiovascular disease (CVD) is the leading cause of mortality worldwide, while depression is highly prevalent in this patient population and has long been regarded as an independent risk ...

Across disciplines, therapeutic areas and even continents, Pfizer scientists have been working to advance understanding of – and potential treatments for – cachexia, a complex metabolic condition ...

MINNEAPOLIS -- Disappointingly, a growth differentiation factor 15 (GDF-15) neutralizer not only failed to improve functional outcomes in heart failure (HF) but was associated with harm in a trial ...

MINNEAPOLIS, MN—Neutralizing growth differentiation factor 15 (GDF-15), a stress-activated cytokine, appears harmful to patients with heart failure (HF). That’s the bottom-line message from the phase ...

One of the fastest-rising cancers in Britain and the US-particularly in under 50s-it is often dubbed a 'silent killer' because it rarely causes symptoms until it is advanced.

Cachexia in older SCLC patients leads to inferior survival rates and increased treatment complications, such as dose reductions and incomplete chemotherapy courses. Patients with cachexia had ...

When someone you love is facing advanced cancer, the heartbreak often goes beyond the diagnosis itself. It's not just the physical pain, the relentless treatments, or the visible transformations of ...